Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Viridian Therapeutics Announces Clinical Data In Healthy Volunteer Study And Selects VRDN-003 As Potential Subcutaneous Anti-IGF-1R Program With Extended Half-life For Development In Thyroid Eye Disease

Author: Benzinga Newsdesk | December 18, 2023 08:14am

Posted In: VRDN